Azumi Y - Search Results

1

Thrombomodulin administration attenuates ischemia-reperfusion injury of the remnant liver after 70% hepatectomy in rats: simulated model of small-for-size graft in living donor liver transplantation.

Tanemura A, Kuriyama N, Azumi Y, Ohsawa I, Kishiwada M, Mizuno S, Usui M, Sakurai H, Tabata M, Isaji S. Tanemura A, et al. Among authors: azumi y. Transplant Proc. 2014 May;46(4):1107-11. doi: 10.1016/j.transproceed.2013.11.128. Transplant Proc. 2014. PMID: 24815140

2

Negative prognostic impact of renal replacement therapy in adult living-donor liver transplant recipients: preoperative recipient condition and donor factors.

Iwata H, Mizuno S, Ishikawa E, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamamoto N, Sugimoto K, Shiraki K, Takei Y, Ito M, Isaji S. Iwata H, et al. Among authors: azumi y. Transplant Proc. 2014 Apr;46(3):716-20. doi: 10.1016/j.transproceed.2013.11.113. Transplant Proc. 2014. PMID: 24767332

3

Biliary complications in 108 consecutive recipients with duct-to-duct biliary reconstruction in living-donor liver transplantation.

Mizuno S, Inoue H, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamada R, Yamamoto N, Sugimoto K, Shiraki K, Takei Y, Isaji S. Mizuno S, et al. Among authors: azumi y. Transplant Proc. 2014 Apr;46(3):850-5. doi: 10.1016/j.transproceed.2013.11.035. Transplant Proc. 2014. PMID: 24767364

4

D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.

Tanemura A, Mizuno S, Kato H, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S. Tanemura A, et al. Among authors: azumi y. Transplant Proc. 2016 May;48(4):1025-31. doi: 10.1016/j.transproceed.2015.12.090. Transplant Proc. 2016. PMID: 27320548

5

Long-Term Influence of CYP3A5 Gene Polymorphism on Pharmacokinetics of Tacrolimus and Patient Outcome After Living Donor Liver Transplantation.

Kato H, Usui M, Muraki Y, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Okuda M, Nakatani K, Isaji S. Kato H, et al. Among authors: azumi y. Transplant Proc. 2016 May;48(4):1087-94. doi: 10.1016/j.transproceed.2016.02.012. Transplant Proc. 2016. PMID: 27320564

6

Technical Feasibility and Clinical Outcomes of Interventional Endovascular Treatment for Hepatic Artery Thrombosis After Living-donor Liver Transplantation.

Murata Y, Mizuno S, Kato H, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Fujimori M, Yamanaka T, Nakatsuka A, Yamakado K, Isaji S. Murata Y, et al. Among authors: azumi y. Transplant Proc. 2016 May;48(4):1142-8. doi: 10.1016/j.transproceed.2015.12.092. Transplant Proc. 2016. PMID: 27320575

7

Discontinuation of Hepatitis B Immunoglobulin by Long-term Hepatitis B Vaccine Inoculation in Preventing Hepatitis B Recurrence After Liver Transplantation.

Usui M, Sugimoto K, Kato H, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Takei Y, Isaji S. Usui M, et al. Among authors: azumi y. Transplant Proc. 2016 May;48(4):1179-83. doi: 10.1016/j.transproceed.2015.12.110. Transplant Proc. 2016. PMID: 27320582

8

Influence of Angiotensin-converting Enzyme Genetic Polymorphism on Late Renal Dysfunction After Adult-to-adult Living-donor Liver Transplantation.

Matsui T, Usui M, Fujinaga K, Nakatani K, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Isaji S. Matsui T, et al. Among authors: azumi y. Transplant Proc. 2016 May;48(4):1184-9. doi: 10.1016/j.transproceed.2016.02.014. Transplant Proc. 2016. PMID: 27320583

9

Impact of Splenectomy Just Before Partial Orthotopic Liver Transplantation Using Small-for-Size Graft in Rats.

Kuriyama N, Iizawa Y, Kato H, Murata Y, Tanemura A, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S. Kuriyama N, et al. Among authors: azumi y. Transplant Proc. 2016 May;48(4):1304-8. doi: 10.1016/j.transproceed.2016.02.041. Transplant Proc. 2016. PMID: 27320610

10

Pretransplant Serum Hyaluronic Acid Can Be a Biomarker as a Prognostic Predictor in Adult-to-Adult Living Donor Liver Transplantation.

Mizuno S, Das BC, Iizawa Y, Kato H, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S. Mizuno S, et al. Among authors: azumi y. Transplant Proc. 2017 Jan-Feb;49(1):102-108. doi: 10.1016/j.transproceed.2016.11.019. Transplant Proc. 2017. PMID: 28104115

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters